10.1186/s12933-019-0816-2 42 LiP.LiK.ZouC.TongC.SunL.CaoZ.et al (2020)
Lawsuits against Novo Nordisk claim that it failed to warn users of the risk of the following side effects: Vision loss or changes Gastroparesis (stomach paralysis) Neuropathy with gastroparesis Intestinal blockage (often requiring surgery to repair) Cyclical vomiting Pancreatic cancer Necrotizing pancreatitis Gallbladder disease Blood clots Has Trulicity Harmed You
Well also coordinate with your prescribing clinician to ensure timing aligns with your GLP-1 medication schedule and overall health goals
Thomson, C
The post-discontinuation phase remains the least investigated, although extension studies consistently show that weight regain occurs rapidly, with patients regaining up to two-thirds of the lost weight within one year after withdrawal ( As the field evolves, questions remain about whether the future of obesity and diabetes management will prioritize pharmacotherapy, lifestyle, or a hybrid approach, especially given the challenges of long-term adherence and the broader health impacts of lifestyle change ( This narrative review synthesizes current evidence on GLP-1RAs, including both conventional single-agent therapies and dual GIP/GLP-1 receptor agonists, versus exercise, their combined effects, and the implications for future clinical and public health priorities
CONGRATS Choose Your Free Gift As a thank-you for subscribing, choose one complimentary product below